» Articles » PMID: 32368879

Intense F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

Overview
Date 2020 May 6
PMID 32368879
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Brachial plexopathy is a significant cause of pain and disability in patients with breast cancer. Major causes of brachial plexopathy in patients with breast cancer are metastatic invasion or radiation damage to the plexus. Differentiation between the two pathologies is important for appropriate treatment planning. The complicated anatomy of the plexus makes this a difficult area to image accurately. Magnetic resonance imaging (MRI) is the imaging modality of choice for diagnostic evaluation of these cases. We presented a case to demonstrate the role of F-flourodeoxyglucose positron emission tomography/computerized tomography for confirming metastatic brachial plexopathy when MRI findings were suspicious and for differentiating radiation-induced brachial plexopathy from metastatic plexopathy.

Citing Articles

Navigating the Complexities of Radiation Injuries: Therapeutic Principles and Reconstructive Strategies.

Grosu-Bularda A, Lita F, Hodea F, Bordeanu-Diaconescu E, Cretu A, Dumitru C J Pers Med. 2024; 14(11).

PMID: 39590592 PMC: 11595796. DOI: 10.3390/jpm14111100.

References
1.
Ahmad A, Barrington S, Maisey M, Rubens R . Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. Br J Cancer. 1999; 79(3-4):478-82. PMC: 2362404. DOI: 10.1038/sj.bjc.6690074. View

2.
Wood J, Gawler J, WHITTLE R, Staunton M . Brachial plexopathy in breast carcinoma--an unsolved problem. Eur J Surg Oncol. 1991; 17(3):265-9. View

3.
Tripathi M, Das C, Srivastava A, Bal C, Malhotra A . Metastatic Brachial Plexopathy in a Case of Recurrent Breast Carcinoma Demonstrated on (18)F-FDG PET/CT. Nucl Med Mol Imaging. 2014; 48(1):85-6. PMC: 4035160. DOI: 10.1007/s13139-013-0237-1. View

4.
Thyagarajan D, Cascino T, Harms G . Magnetic resonance imaging in brachial plexopathy of cancer. Neurology. 1995; 45(3 Pt 1):421-7. DOI: 10.1212/wnl.45.3.421. View